Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Mayela Rodriguez‐Violante"'
Autor:
Daniel J. van Wamelen, Anna Sauerbier, Valentina Leta, Carmen Rodriguez-Blazquez, Cristian Falup-Pecurariu, Mayela Rodriguez‐Violante, Alexandra Rizos, Y. Tsuboi, Vinod Metta, Roongroj Bhidayasiri, Kalyan Bhattacharya, Rupam Borgohain, L. K. Prashanth, Raymond Rosales, Simon Lewis, Victor Fung, Madhuri Behari, Vinay Goyal, Asha Kishore, Santiago Perez Lloret, Pablo Martinez-Martin, K. Ray Chaudhuri
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract Growing evidence suggests that non-motor symptoms (NMS) in Parkinson’s disease (PD) have differential progression patterns that have a different natural history from motor progression and may be geographically influenced. We conducted a cr
Externí odkaz:
https://doaj.org/article/253a5f52cf804525a1285587c2b2f3ff
Publikováno v:
Frontiers in Neurology, Vol 12 (2021)
Externí odkaz:
https://doaj.org/article/fb9b79578a2642a19e1763592dc8a71b
Autor:
Reinhard Janssen-Aguilar, Patricia Rojas, Elizabeth Ruiz-Sánchez, Mayela Rodriguez-Violante, Yessica M. Alcántara-Flores, Daniel Crail-Meléndez, Amin Cervantes-Arriaga, Óscar Sánchez-Escandón, Ángel A. Ruiz-Chow
Publikováno v:
Brain Sciences, Vol 12, Iss 3, p 326 (2022)
Major depressive disorder (MDD) is a major health problem in Parkinson’s disease (PD) patients. We described the clinical and sociodemographic factors of MDD among patients with PD at a national neurological referral center in Mexico. One hundred p
Externí odkaz:
https://doaj.org/article/2bb1dc2536824f899651044455fb9e85
Autor:
Daniel Martinez-Ramirez, Edna Sophia Velazquez-Avila, Alejandro Almaraz-Espinoza, Arnulfo Gonzalez-Cantú, Genaro Vazquez-Elizondo, Daniel Overa-Posada, Amin Cervantes-Arriaga, Mayela Rodriguez-Violante, Mirna Gonzalez-Gonzalez
Publikováno v:
Parkinson's Disease, Vol 2020 (2020)
Purpose. Autonomic dysfunction is a common nonmotor feature and early manifestation of Parkinsons disease (PD). Autonomic dysfunction in PD is associated with a worse prognosis. We sought to characterize autonomic dysfunction and identify associated
Externí odkaz:
https://doaj.org/article/89ce45f8175b42c2bfcd1fab6d33043f
Publikováno v:
Parkinson's Disease, Vol 2019 (2019)
Externí odkaz:
https://doaj.org/article/857290bf5ca34e4fb368116cb5b74162
Autor:
Valentina, Leta, Iro, Boura, Daniel J, van Wamelen, Mayela, Rodriguez-Violante, Angelo, Antonini, Kallol Ray, Chaudhuri
Publikováno v:
International review of neurobiology. 165
The Coronavirus Disease 2019 (Covid-19), caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), has led to unprecedented challenges for the delivery of healthcare and has had a clear impact on people with chronic neurological con
Autor:
Silvia, Rota, Iro, Boura, Yi-Min, Wan, Claudia, Lazcano-Ocampo, Mayela, Rodriguez-Violante, Angelo, Antonini, Kallol Ray, Chaudhuri
Publikováno v:
International review of neurobiology. 165
The Coronavirus Disease 2019 (Covid-19) pandemic has profoundly affected the quality of life (QoL) and health of the general population globally over the past 2 years, with a clear impact on people with Parkinson's Disease (PwP, PD). Non-motor sympto
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Valentina Leta, Iro Boura, Daniel J. van Wamelen, Mayela Rodriguez-Violante, Angelo Antonini, Kallol Ray Chaudhuri
Publikováno v:
International Review of Neurobiology ISBN: 9780323991735
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9e1989a7d0cfa863fe12169c59bf1129
https://doi.org/10.1016/bs.irn.2022.04.004
https://doi.org/10.1016/bs.irn.2022.04.004
Autor:
Mayela Rodríguez-Violante, Ana J. Hernández-Medrano, Amin Cervantes-Arriaga, Cesarina Torres-Vásquez, Dioselina Tristán-Samaniego, Carolina Zepeda-Salazar, Victoria Cerino-Palomino, Arturo Abundes-Velasco
Publikováno v:
Revista de Investigación Clínica, Vol 76, Iss 3 (2024)
Monotherapy is the recommended initial treatment for early Parkinson’s disease. The pharmacological options for initial treatment include dopaminergic agonists, monoamine oxidase B inhibitors, and levodopa formulations. Several factors should be co
Externí odkaz:
https://doaj.org/article/5c16c70c3c5d4a5198b7b7d852907d14